Market capitalization | €4.64b |
Enterprise Value | €4.72b |
PER (TTM) P/E ratio | 52.62 |
EV/FCF (TTM) EV/FCF | 53.36 |
P/B ratio (TTM) P/B ratio | 2.58 |
Dividend yield | 0.93% |
Last dividend (FY24) | €0.97 |
Sales growth (TTM) Sales growth | -100.00% |
Turnover (TTM) Turnover | €0.00 |
As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.
2 Analysts have issued a Financière De Tubize forecast:
2 Analysts have issued a Financière De Tubize forecast:
Dec '23 |
+/-
%
|
||
Turnover | - - |
-
|
|
Gross income | - - |
-
|
|
EBITDA | -1.89 -1.89 |
1%
1%
|
EBIT (operating result) EBIT | -1.89 -1.89 |
0%
0%
|
Net profit | 88 88 |
3%
3%
|
Figures in millions EUR.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
Financiere de Tubize SA is a holding company, which engages in investing in biopharmaceuticals industry. The company was founded on June 30, 1928 and is headquartered in Brussels, Belgium.
Head office | Belgium |
CEO | Anne-Sophe Pijcke |
Founded | 1928 |
Website | www.financiere-tubize.be |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.